Picard Medical Unveils Next-Gen Artificial Heart Tech at IEEE EMBC 2026
Event summary
- Picard Medical will present its next-generation Emperor Total Artificial Heart technology at IEEE EMBC 2026 on July 29, 2026.
- Taha Hasekioglu, Director and Emperor Program Lead, will introduce the Emperor Drive System architecture to the biomedical engineering community.
- The presentation marks the first public scientific introduction of the Emperor Drive System's design principles and development progress.
- Picard Medical aims to combine SynCardia’s proven artificial heart ventricles with its next-generation electromechanical drive system.
The big picture
Picard Medical’s presentation of the Emperor Total Artificial Heart technology underscores its commitment to advancing mechanical circulatory support. The company is leveraging decades of SynCardia experience while incorporating new engineering approaches, positioning itself at the forefront of artificial heart innovation. With over 2,100 implants globally, Picard Medical aims to expand patient access and solidify its leadership in total artificial heart technology.
What we're watching
- Technological Integration
- How Picard Medical will integrate the Emperor Drive System with SynCardia’s existing artificial heart ventricles.
- Regulatory Approval
- Whether the next-generation technology will secure FDA and Health Canada approvals as swiftly as its predecessor.
- Market Adoption
- The pace at which hospitals and transplant centers adopt the Emperor Total Artificial Heart once it becomes commercially available.